Seminars in Hematology
Volume 45, Issue 4 , Pages 255-260 , October 2008

Functional Outcomes of Anemia in Older Adults

  • Paulo H.M. Chaves

      Affiliations

    • Corresponding Author InformationAddress correspondence to Paulo H.M. Chaves, MD, PhD, 2024 E Monument St, Suite 2-700, Baltimore, MD 21205

References 

  1. Fried LP, Guralnik JM. Disability in older adults: Evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92–100
  2. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women (Should the criteria currently used to define anemia in older people be reevaluated?). J Am Geriatr Soc. 2002;50:1257–1264
  3. World Health Organization Technical Report Series No. 405. Nutritional Anaemias: Report of a WHO Scientific Group. Geneva, Switzerland: WHO; 1968;
  4. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561
  5. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med. 2003;115:104–110
  6. Fried L, Walston J. Frailty and the failure to thrive. In:  Hazzard WR,  Blass JP,  Halter JB,  Ouslander JG,  Tinetti ME editor. Principles of Geriatric Medicine and Gerontology. (ed 5). New York, NY: McGraw-Hill; 2003;p. 1487–1502
  7. Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J, et al. Fraility in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56A:M146–M156
  8. Chaves PHM, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: The Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2005;60:729–735
  9. Bandeen-Roche K, Xue QL, Ferrucci L, Walston J, Guralnik JM, Chaves PHM, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262–266
  10. Chaves PHM, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc. 2004;52:1811–1816
  11. Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: The impact of chronic kidney disease. J Am Soc Nephrol. 2005;16:3403–3410
  12. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol. 2003;14:2919–2925
  13. Roubenoff R. Sarcopenia: A major modifiable cause of frailty in the elderly. J Nutr Health Aging. 2000;4:140–142
  14. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719–724
  15. Schultz-Larsen K, Avlund K. Tiredness in daily activities: A subjective measure for the identification of frailty among non-disabled community-living older adults. Arch Gerontol Geriatr. 2007;44:83–93
  16. Cella D. Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol. 1998;25(suppl 7):43–46
  17. Avlund K, Rantanen T, Schroll M. Tiredness and subsequent disability in older adults: The role of walking limitations. J Gerontol A Biol Sci Med Sci. 2006;61:1201–1205
  18. Evans WJ, Lambert CP. Physiological basis of fatigue. Am J Phys Med Rehabil. 2007;86(suppl):S29–S46
  19. Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K. Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res. 2007;13:6379–6385
  20. Xue Q-L, Fried LP, Glass TA, Laffan A, Chaves PHM. Life-space constriction, development of frailty, and the competing risk of mortality: The Women's Health and Aging Study I. Am J Epidemiol. 2008;167:240–248
  21. Xue QL, Bandeen Roche K, Zhou J, Varadhan R, Fried LP: Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci (in press)
  22. Penninx BW, Pluijm SM, Lips P, Woodman R, Miedema K, Guralnik JM, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53:2106–2111
  23. Lawrence VA, Silverstein JH, Cornell JE, Pederson T, Noveck H, Carson JL. Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion. 2003;43:1717–1722
  24. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PHM, Newman AB, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: The Cardiovascular Health Study. Arch Intern Med. 2005;165:2214–2220
  25. Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006;61:474–479
  26. Beard CM, Kokmen E, O'Brien PC, Anía BJ, Melton LJ. Risk of Alzheimer's disease among elderly patients with anemia: Population-based investigations in Olmsted County, Minnesota. Ann Epidemiol. 1997;7:219–224
  27. Atti AR, Palmer K, Volpato S, Zuliani G, Winblad B, Fratiglioni L. Anaemia increases the risk of dementia in cognitively intact elderly. Neurobiology Aging. 2006;27:278–284
  28. Chaves PH, Carlson MC, Ferrucci L, Guralnik JM, Semba R, Fried LP. Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc. 2006;54:1429–1435
  29. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006;119:327–334
  30. Chaves PHM, Mody SH, Blasi MV, Siegartel LR, Stern LS, Doyle JJ, et al. Healthcare costs and resource utilization associated with chronic anemia in older adults. J Managed Care Med. 2005;8:13–20
  31. Cesari M, Pahor M, Lauretani F, Penninx BW, Bartali B, Russo R, et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI. Osteoporos Int. 2005;16:691–699
  32. Gehi A, Ix J, Shlipak M, Pipkin SS, Whooley MA. Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol. 2005;95:1474–1477
  33. Kramer AF, Hahn S, Cohen NJ, Banich MT, McAuley E, Harrison CR, et al. Ageing, fitness and neurocognitive function. Nature. 1999;400:418–419
  34. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14:125–130
  35. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15:3184–3191
  36. Astor BC, Arnett DK, Brown A, Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2004;43:836–845
  37. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2006;151:492–500
  38. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis. 2007;50:471–530
  39. Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Ann Oncol. 2004;15:979–986
  40. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol. 2008;26:132–149
  41. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–2098
  42. Drueke TB, Locatelli F, Clyne N, Eckardt K-U, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–2084
  43. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis. 2005;46:799–811
  44. Roger SD, McMahon LP, Clarkson A, Disney A, Harris D, Hawley C, et al. Effects of early and late intervention with epoetin {alpha} on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol. 2004;15:148–156
  45. Locatelli F, Del Vecchio L, Pozzoni P. Anemia and cardiovascular risk: The lesson of the CREATE trial. J Am Soc Nephrol. 2006;17(suppl 3):S262–S266
  46. Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, et al. Chronic anemia and fatigue in elderly patients: Results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55:1557–1565
  47. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol. 2006;17:146–150
  48. O'Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, et al. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer. 2005;5:439–446
  49. Marsh JT, Brown WS, Wolcott DL, Carr CR, Harper R, Schweitzer SV, et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int. 1991;39:155–163
  50. Stivelman JC. Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant. 2000;15(suppl 3):29–35
  51. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med. 2005;118:1288
  52. Patel KV, Harris TB, Faulhaber M, Angleman SB, Connelly S, Bauer DC, et al. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood. 2007;109:4663–4670

 Supported in part by the Johns Hopkins Older Americans Independence Center - National Institute on Aging (NIA) P30 AG021334, and the NIA Grant No. R37 AG19905. Dr Chaves has been the recipient of study grants by Ortho Biotech, LP, and Amgen, Inc, and has served as consultant for Ortho Biotech, LP, Amgen, Inc, and FibroGen, Inc.

PII: S0037-1963(08)00107-8

doi: 10.1053/j.seminhematol.2008.06.005

Seminars in Hematology
Volume 45, Issue 4 , Pages 255-260 , October 2008

Article Tools

* Image Usage & Resolution